Advertisement

Journal of Neurology

, Volume 244, Issue 4, pp 266–270 | Cite as

Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images

  • Marco Rovaris
  • Massimo Filippi
  • Giliola Calori
  • Mariemma Rodegher
  • Adriana Campi
  • Bruno Colombo
  • Giancarlo Comi
Original Communication

Abstract

New magnetic resonance (MR) measures considered to be putative markers of demyelination and axonal loss were found to be more closely related to clinical disability than T2-weighted MR imaging (MRI) findings in patients with multiple sclerosis (MS). In this study, we evaluated the reproducibility of such measurements in order to assess their reliability for longitudinal studies in MS. The intra-observer coefficients of variation for repeated measurements did not significantly differ among the MR techniques studied [2.6% for T2-weighted MRI, 4.38% for unenhanced T1-weighted MRI, 3.65% for magnetisation transfer imaging (MTI) and 2.28% for spinal cord cross-sectional area at C5]. Our findings suggest that non-conventional MR techniques may be reliable outcome measures for clinical trials in MS.

Key words

Multiple sclerosis Magnetic resonance imaging Magnetisation tranfer imaging Spinal cord Measurement reproducibility 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bland JM, Altaian DG (1986) Statistical methods of assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefGoogle Scholar
  2. 2.
    British Standards Institution (1979) Precision of test methods. I. Guide for the determination and reproducibility of a standard test method. British Standard 5497Google Scholar
  3. 3.
    Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117: 49–58CrossRefGoogle Scholar
  4. 4.
    Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 118:1583–1592CrossRefGoogle Scholar
  5. 5.
    De Stefano N, Matthews PM, Antel JP, Preul M, Francis GS, Arnold DL (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38: 901–909CrossRefGoogle Scholar
  6. 6.
    Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, Lavi E, Cohen JA (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182:483–491CrossRefGoogle Scholar
  7. 7.
    Filippi M, Barker GJ, Horsfield MA, Sacares PR, MacManus DG, Thompson AJ, Tofts PS, McDonald WI, Miller DH (1994) Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 241:246–251CrossRefGoogle Scholar
  8. 8.
    Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, Scotti G, Comi G (1995) A magnetisation transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478–482CrossRefGoogle Scholar
  9. 9.
    Filippi M, Horsfield MA, Bressi S, Martinelli V, Baratti C, Reganati P, Campi A, Miller DH, Comi G (1995) Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis: a comparison of techniques. Brain 118:1583–1592CrossRefGoogle Scholar
  10. 10.
    Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ Miller DH (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118:1601–1612CrossRefGoogle Scholar
  11. 11.
    Filippi M, Horsfield MA, Gasperini C, Waesberghe JH van, Gawne-Cain ML, Rocca MA, Bastianello S, Lycklama è Nijeholt GJ, Miller DH (1996) Inter-scanner variation in brain MRI lesion load measurement in multiple sclerosis. Proc Fourth Sci Meeting Int Soc Magn Reson Med 1:171Google Scholar
  12. 12.
    Filippi M, Campi A, Colombo B, Pereira C, Martinelli V, Baratti C, Comi G (in press) A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 243:502–505CrossRefGoogle Scholar
  13. 13.
    Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus DG, Brennan A, Tofts PS, Thompson AJ, McDonald WI, Miller DH (1994) Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 36:62–67CrossRefGoogle Scholar
  14. 14.
    Gawne-Cain ML, Webb S, Tofts PS, Miller DH (1996) The effect of repositioning inaccuracies on intracranial MS lesion volume measurements (abstract). Proc Fourth Sci Meeting Int Soc Magn Reson Med 1:534Google Scholar
  15. 15.
    Grimaud J, Lai M, Thorpe JW, Adeleine P, Plummer D, Barker GJ, Wang L, Tofts PS, McDonald WI, Miller DH (1995) Evaluation of computer-assisted quantification of MS lesions in cranial MR imaging (abstract). Proc Third Sci Meeting Int Soc Magn Reson Med 1:283Google Scholar
  16. 16.
    Grossman RI (1994) Magnetization transfer in multiple sclerosis. Ann Neurol 36: S97-S99CrossRefGoogle Scholar
  17. 17.
    Hiehle JF, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA (1995) Magnetization transfer effect in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and non-enhanced T1-weighted images. AJNR 16:69–77PubMedGoogle Scholar
  18. 18.
    Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, McDonald WI, Miller DH (1993) Spinal cord MRI using multi-array coils and fast-spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632–2637CrossRefGoogle Scholar
  19. 19.
    Loevener LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA (1995) Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR 16:1473–1479Google Scholar
  20. 20.
    Losseff N, Lai M, Miller DH, McDonald WI, Thompson AJ (1995) The prognostic value of serial axial cord area measurement by magnetic resonance imaging in multiple sclerosis (abstract). J Neurol 242 [Suppl 2]: 110Google Scholar
  21. 21.
    Miller DH (1994) Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 36: S91-S94CrossRefGoogle Scholar
  22. 22.
    Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683–688CrossRefGoogle Scholar
  23. 23.
    Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39:6–16CrossRefGoogle Scholar
  24. 24.
    Paty DW, Li DKB, UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662–667CrossRefGoogle Scholar
  25. 25.
    Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231CrossRefGoogle Scholar
  26. 26.
    Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, Maloni H, McFarlin DE, McFarland HF (1993) Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33: 480–489CrossRefGoogle Scholar
  27. 27.
    Van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin STFM, Valk J (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (T1-weighted) spin-echo images. Neurology 45:1684–1690CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Marco Rovaris
    • 1
  • Massimo Filippi
    • 1
  • Giliola Calori
    • 3
  • Mariemma Rodegher
    • 1
  • Adriana Campi
    • 2
  • Bruno Colombo
    • 1
  • Giancarlo Comi
    • 1
  1. 1.MS Biosignal Analysis Centre, Department of Neurology, Scientific Institute Ospedale San RaffaeleUniversity of MilanMilanItaly
  2. 2.Department of Neuroradiology, Scientific Institute Ospedale San RaffaeleUniversity of MilanMilanItaly
  3. 3.Department of Medical Statistics, Scientific Institute Ospedale San RaffaeleUniversity of MilanMilanItaly

Personalised recommendations